Home > Insider Trading > Filing (0000899243-22-034702)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831868	Seastar Medical Holding Corp	ICU	Surgical & Medical Instruments & Apparatus (3841)	853681132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1951900	Trust Plan Pension Employees' Dow	Sylvia Stoesser Center 2211 H.h. Dow Way Midland MI 48674		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-10-28	4,149,841	$0.00	4,149,841	No	4	A	Direct
Common Stock	Acquisiton	2022-10-28	300,000	$0.00	4,449,841	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to Buy)	Acquisiton	2022-10-28	1,726	$0.00	1,726	$10.00
Common Stock	Warrants (Right to Buy)	Acquisiton	2022-10-28	300,000	$0.00	300,000	$11.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,726		2025-06-20	No	4	A	Direct
300,000		2027-10-28	No	4	P	Direct

Footnotes

On October 28, 2022, LMF Acquisition Opportunities, Inc., a Delaware corporation ("LMF"), consummated a business combination (the "Business Combination") by and among LMF, LMF Merger Sub, Inc., a Delaware corporation and directly wholly-owned subsidiary of LMF ("Merger Sub") and SeaStar Medical, Inc., a Delaware corporation ("SeaStar Medical"), pursuant to which SeaStar Medical merged with and into Merger Sub, with SeaStar Medical continuing as the surviving entity in the merger as a wholly-owned subsidiary of LMF, and with LMF changing its name to SeaStar Medical Holding Corporation ("SeaStar Medical Holdings"). As part of the Business Combination each share of SeaStar Medical stock was exchanged for 1.20321 shares of common stock of SeaStar Medical Holdings ("Common Stock").
In a concurrent private placement in connection with the Business Combination, the Reporting Person acquired 300,000 shares of Common Stock and warrants to purchase 300,000 shares of Common Stock for an aggregate purchase price of $3,000,000.
The warrants are fully exercisable.
As part of the Business Combination, each SeaStar Medical warrant was exchanged for a warrant to purchase 1.20321 shares of Common Stock.
The warrants are fully exercisable